EQT Agrees $12.1 Billion Purchase of Qiagen

Private equity firm EQT has agreed to acquire molecular testing company Qiagen for about $12.1 billion. The deal shows continued investor demand for businesses with specialist technology, strong customers and a clear role in healthcare. HPC can use this as a signal to source medical testing, laboratory and healthcare technology businesses for private equity and strategic buyers.

If you are interested to enquire further, please fill in the form below with your details and one of our consultants will contact you shortly.